In Vitro Diagnostics: Technologies and Global Markets

  • ID: 4438554
  • Report
  • Region: Global
  • 220 Pages
  • BCC Research
15 % OFF
until Oct 31st 2018
1 of 5
The Global in Vitro Diagnostics (IVD) Market Should Reach $102.4 Billion by 2022 from $74.1 Billion in 2017 at a CAGR of 6.7%, from 2017 to 2022

FEATURED COMPANIES

  • Abbott Diagnostics Inc.
  • Alere San Diego Inc.
  • Ascensia Diabetes Care
  • Bio-Rad
  • Elitech Group
  • Hologic Inc.
  • MORE

This report offers a comprehensive analysis of the global in-vitro diagnostic market, along with an in- depth study of the various in vitro diagnostics (IVD). Segments include clinical chemistry, immunoassays, point-of-care diagnostics, molecular diagnostics, hematology, microbiology and tissue diagnostics. The regional markets covered are North America, Europe, Asia-Pacific and LAAM (Latin America/Africa/Middle East).

This report provides a complete review and analysis of the current trends in the IVD markets, along with industry growth drivers and restraints. Revenues are broken down by regions, segments, products and end users, and sales figures have been estimated for the five-year period from 2017 through 2022 in constant U.S. dollars.

In addition, it provides an examination and description of select products, current and emerging technologies, and company profiles. Applications for IVD are also discussed, with an emphasis on the use of these types of tests in various disease sectors. Further, the report offers a view on IVD patents, regulatory aspects and emerging developments in the IVD market across the globe.

Report highlights:

  • The global in vitro diagnostics (IVD) market should reach $102.4 billion by 2022 from $74.1 billion in 2017 at a compound annual growth rate (CAGR) of 6.7%, from 2017 to 2022.
  • The North America region of the global IVD market is the largest market. The market is expected to grow from $31.1 billion in 2017 to $36.9 billion in 2022 at a CAGR of 3.4% for the period 2017-2022.
  • The Asia-Pacific region of the global IVD market is expected to grow from $18.5 billion in 2017 to $34.8 billion in 2022 at a CAGR of 13.5% for the period 2017-2022.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Diagnostics Inc.
  • Alere San Diego Inc.
  • Ascensia Diabetes Care
  • Bio-Rad
  • Elitech Group
  • Hologic Inc.
  • MORE

1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Readership
Scope of Report
Methodology
Geographic Breakdown
Analyst's Credentials

2 Summary and Highlights
Global Market Trends

3 Market Landscape
Market Overview and Segmentation
Key Findings
Factors Influencing the Global IVD Market
Challenges
Regulatory Landscape

4 Market Breakdown by Product Segment
Introduction
Description
Immunochemistry
POC Testing
Molecular Diagnostics
Hematology
Clinical Microbiology
Tissue Diagnostics
Trends in IVD Segments
Competitive Structure
Market Share Analysis

5 Global Immunochemistry Market
Applications
Blood Gas, Electrolytes and Metabolites (BGEM)
Endocrine
Infectious Diseases
Cancer
Urinalysis
Diabetes
Cardiology
Blood Screening
Others

6 Global POC Testing Market
Applications
Glucose Testing
BGEM
Cardiac Marker Testing
Infectious Disease Testing
Pregnancy and Fertility Testing
Drug and Alcohol Abuse Testing
Hematology and Hemostasis Testing
Cholesterol Testing
Urine Chemistry Testing
Tumor Marker Testing
Other POC Testing

7 Global Hematology Market
Applications
Routine Hematology Tests
Hemostasis

8 Global Molecular Diagnostics Market
Applications
Infectious Diseases
Blood Screening
Oncology
Genetic Testing
Others (Companion Diagnostics, Prenatal Genetic Tests and Rare Diseases)

9 Global Clinical Microbiology Market
Applications
Blood Culture
General Culture (urine/saliva/stool/sputum/CSF and other Body fluids)
Identification and Antibiotic Susceptibility Testing

10 Global Tissue Diagnostics Market
Applications
Cancer Diagnosis
Tissue Typing
Pathogen Detection

11 Market Breakdown by End Users
Introduction
Trends

12 Global IVD Market Products
Introduction
Trends

13 Regional Analysis
Introduction
North America
Europe
Asia-Pacific
LAAM
International Health Expenditure and Trends
North America
Europe
Western Europe
Central and Eastern Europe
Asia-Pacific
Latin America, Africa and Middle East (LAAM)

14 Emerging Global Technology and Trends
Trends
Industry Developments
Opportunity Areas
IVD for Neglected Infectious Diseases
Portable Devices Compatible with Simple Detection Platforms
Chemistry-Based Portable Analyzers
Improved Sample Preservation Technologies
New Detection Technologies
Alternative Technologies to PCR
Key Biomarkers for Diseases of the Developing World
Microfluidic Platform-based POC Tests for Remote Settings
Combining Multiple Detection Technologies into a Single Instrument

15 Mergers and Acquisitions

16 Patent Review
Immunochemistry
Point of Care Testing
Molecular Diagnostics
Hematology
Clinical Microbiology
Tissue Diagnostics

17 Company Profiles
Abbott Diagnostics Inc.
Alere San Diego Inc.
Ascensia Diabetes Care
Beckman Coulter (Part of Danaher)
Becton Dickinson and Company
Biomerieux
Bio-Rad
Elitech Group
Hologic Inc.
Kem-En-Tec Diagnostics A/S
Ortho Clinical Diagnostics
Roche Diagnostics Corp.
Siemens Healthcare Diagnostics Inc.
Sysmex
Thermo Fisher Scientific Inc.
Transasia Bio-Medicals
Werfen Group

18 Appendix
List of IVD Market Participants
List of Abbreviations

List of Tables:
Summary Table: Global Market for In Vitro Diagnostics (IVD), by Region, Through 2022
Table 1: Types of Diagnostic Tests and How They Are Regulated
Table 2: Changes in IVD Regulations in Asia
Table 3: Global IVD Market, by Segment, Through 2022
Table 4: Global IVD Market Share, by Major Market Companies, 2017
Table 5: Global Immunochemistry Market, by Application, Through 2022
Table 6: Global Immunochemistry Market, by Region, Through 2022
Table 7: Global POC Testing Market by Application, Through 2022
Table 8: Global POC Testing Market, by Region, Through 2022
Table 9: Global Hematology Market, by Application, Through 2022
Table 10: Global Hematology Market, by Region, Through 2022
Table 11: Global Molecular Diagnostics Market, by Application, Through 2022
Table 12: Global Molecular Diagnostics Market, by Region, Through 2022
Table 13: List of Cleared or Approved Companion Diagnostic Devices, by Drug Trade Name
Table 14: List of Cleared or Approved Human Genetic Tests
Table 15: Global Clinical Microbiology Market by Application, Through 2022
Table 16: Global Clinical Microbiology Market, by Region, Through 2022
Table 17: List of FDA-Approved Microbial Tests, 2017
Table 18: Global Tissue Diagnostics Market, by Application, Through 2022
Table 19: Global Tissue Diagnostics Market, by Region, Through 2022
Table 20: Global IVD Market, by Region, Through 2022
Table 21: Global IVD Market Share, by Region, 2016-2022
Table 22: North American IVD Market, by Segment, Through 2022
Table 23: North American Immunochemistry Market, by Segment, Through 2022
Table 24: North American POC Market, by Segment, Through 2022
Table 25: North American Hematology Market, by Segment, Through 2022
Table 26: North American Molecular Diagnostics Market, by Segment, Through 2022
Table 27: North American Microbiology Market, by Segment, Through 2022
Table 28: North American Tissue Diagnostics Market, by Segment, Through 2022
Table 29: European IVD Market, by Segment, Through 2022
Table 30: European Immunochemistry Market, by Segment, Through 2022
Table 31: European POC Market, by Segment, Through 2022
Table 32: European Hematology Market, by Segment, Through 2022
Table 33: European Molecular Diagnostics Market, by Segment, Through 2022
Table 34: European Microbiology Market, by Segment, Through 2022
Table 35: European Tissue Diagnostics Market, by Segment, Through 2022
Table 36: Asia-Pacific IVD Market Share, by Country, 2017
Table 37: Asia-Pacific IVD Market, by Segment, Through 2022
Table 38: Asia-Pacific Immunochemistry Market, by Segment, Through 2022
Table 39: Asia-Pacific POC Market, by Segment, Through 2022
Table 40: Asia-Pacific Hematology Market, by Segment, Through 2022
Table 41: Asia-Pacific Molecular Diagnostics Market, by Segment, Through 2022
Table 42: Asia-Pacific Microbiology Market, by Segment, Through 2022
Table 43: Asia-Pacific Tissue Diagnostics Market, by Segment, Through 2022
Table 44: LAAM IVD Market, by Segment, Through 2022
Table 45: LAAM Immunochemistry Market, by Segment, Through 2022
Table 46: LAAM POC Market, by Segment, Through 2022
Table 47: LAAM Hematology Market, by Segment, Through 2022
Table 48: LAAM Molecular Diagnostics Market, by Segment, Through 2022
Table 49: LAAM Microbiology Market, by Segment, Through 2022
Table 50: LAAM Tissue Diagnostics Market, by Segment, Through 2022
Table 51: IVD High-Complexity U.S. FDA Product Approvals, 2017
Table 52: Diagnostics Manufacturer Mergers and Acquisitions, 2004-2017
Table 53: Immunochemistry In Vitro Diagnostics Patents Granted, 2016 and 2017
Table 54: POC In Vitro Diagnostics Patents Granted, 2016 and 2017
Table 55: Molecular In Vitro Diagnostics Patents Granted, 2016 and 2017
Table 56: Hematology In Vitro Diagnostics Patents Granted, 2017
Table 57: Clinical Microbiology In Vitro Diagnostics Patents Granted, 2016 and 2017
Table 58: Tissue In Vitro Diagnostics Patents Granted, 2016-2017
Table 59: Significant Companies Purchased by Thermo Fisher Scientific

List of Figures:
Summary Figure: Global Market for In Vitro Diagnostics (IVD), by Region, 2016-2022
Figure 1: Global IVD Market, by Segment, 2016-2022
Figure 2: Global IVD Market Share, by Segment, 2017
Figure 3: Global Immunochemistry Market Share, by Application, 2017
Figure 4: Global Immunochemistry Market, by Region, 2016-2022
Figure 5: Global POC Testing Market, by Application, 2016-2022
Figure 6: Global POC Testing Market, by Region, 2016-2022
Figure 7: Global Hematology Market, by Application, 2016-2022
Figure 8: Global Hematology Market Share, by Technique, 2017
Figure 9: Global Hematology Market Share, by System, 2017
Figure 10: Global Hematology Market, by Region, 2016-2022
Figure 11: Global Molecular Diagnostics Market, by Application, 2016-2022
Figure 12: Global Molecular Diagnostics Market Share, by Application, 2017
Figure 13: Global Molecular Diagnostics Market Share, by Infectious Disease, 2017
Figure 14: Global Molecular Diagnostics Market, by Region, 2016-2022
Figure 15: Global Clinical Microbiology Market, by Application, 2016-2022
Figure 16: Global Clinical Microbiology Market Share, by Application, 2017
Figure 17: Global Clinical Microbiology Market, by Region, 2016-2022
Figure 18: Global Tissue Diagnostics Market, by Application, 2016-2022
Figure 19: Global Tissue Diagnostics Market Share, by Application, 2017
Figure 20: Global Tissue Diagnostics Market, by Region, 2016-2022
Figure 21: Global IVD Market Share, by End User, 2017
Figure 22: Global IVD Market Share, by Product Type, 2017
Figure 23: Total Health Expenditure as a Percentage of GDP for the Top Industrialized Economies, 2015
Figure 24: European IVD Market Share, by Country, 2017
Figure 25: Western European IVD Market Share, by Country, 2017
Figure 26: Central and Eastern European IVD Market Share, by Country, 2017
Figure 27: Latin American IVD Market Share, by Country, 2017
Figure 28: Middle East and African IVD Market Share, by Region, 2017

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Diagnostics Inc.
  • Alere San Diego Inc.
  • Ascensia Diabetes Care
  • Beckman Coulter (Part of Danaher)
  • Becton Dickinson And Company
  • Bio-Rad
  • Elitech Group
  • Hologic Inc.
  • Kem-En-Tec Diagnostics A/S
  • Ortho Clinical Diagnostics
  • Roche Diagnostics Corp.
  • Siemens Healthcare Diagnostics Inc.
  • Sysmex
  • Thermo Fisher Scientific Inc.
  • Transasia Bio-Medicals
  • Werfen Group
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll